Rossmed Lifesciences Private Limited, a active private limited company, was established on 04 December 2003 in Kozhikode, Kerala, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24232KL2003PTC016666. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹9.00 M and a paid-up capital of ₹7.90 M.
It upholds a compliant status. Employing 22 professional, Its leadership includes Jahangeer Moothattu Kalachalilakath (Managing Director), Sreekumar Avinhikkati (Director), Na Udayakumar (Director). It holds ₹1.00 Cr open charges and ₹5.50 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 11/495 D, Keyar Complex 8/4 Chungam, Feroke, Kozhikode, Kerala, 673631.
U24232KL2003PTC016666
016666
04 December 2003
₹9.00 M
₹7.90 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Rossmed Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jahangeer Moothattu Kalachalilakath | Managing Director | 04 Dec 2003 | Current |
| Sreekumar Avinhikkati | Director | 04 Dec 2003 | Current |
| Na Udayakumar | Director | 20 Feb 2023 | Current |
| Elakkat Rajasekhar | Director | 04 Dec 2003 | Current |
| Gopalapillai Reghu | Director | 01 Feb 2005 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rossmed Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 15.29% increase. The company also saw a substantial improvement in profitability, with a 368.32% increase in profit. The company's net worth moved up by a moderate rise of 8.77%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Rossmed Lifesciences had a promoter holding of 94.89% and a public holding of 5.11%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹10,000,000.00
₹5,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jan 2025 | Others | ₹7.50 M | Open |
| 21 Oct 2024 | Others | ₹2.50 M | Open |
| 16 Aug 2023 | Idbi Bank Limited | ₹2.50 M | Satisfied |
| 14 Sep 2012 | Hdfc Bank Limited | ₹3.00 M | Satisfied |
Explore comprehensive loan charge details -
Rossmed Lifesciences has a workforce of 22 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Rossmed Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rossmed Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Others amounted to Rs. 7.50 M with Charge ID 101044555 was registered on 27 Jan 2025. was completed.
Progress on A charge registered on 16 Aug 2023 via Charge ID 100776467 with Idbi Bank Limited was fully satisfied on 02 Nov 2024. was documented.
The activity A charge with Others amounted to Rs. 2.50 M with Charge ID 101018633 was registered on 21 Oct 2024. was completed.
Rossmed Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Rossmed Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was documented.
Progress on A charge with Idbi Bank Limited amounted to Rs. 2.50 M with Charge ID 100776467 was registered on 16 Aug 2023. was documented.
The CIN of Rossmed Lifesciences Private Limited is U24232KL2003PTC016666.
Rossmed Lifesciences Private Limited is headquartered at 11/495 D, Keyar Complex 8/4 Chungam, Feroke, Kozhikode, Kerala, 673631.
Rossmed Lifesciences Private Limited was incorporated on 04 December 2003.
The current directors of Rossmed Lifesciences Private Limited are
The primary industry of Rossmed Lifesciences Private Limited is Trade.
Rossmed Lifesciences Private Limited is unlisted.
The authorized capital of Rossmed Lifesciences Private Limited is ₹9.00 M, and the paid-up capital is ₹7.90 M.
The compliance status of Rossmed Lifesciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX